BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Special Mergers and Acquisitions

VSA Signs LOI to Acquire HopeAI, Advancing Entry into AI-Driven Clinical Development

TCTM Kids IT Education Inc. (Nasdaq: VSA) (the "Company" or "VSA") today announced that it has entered into a non-binding letter of intent ("LOI") to acqui...

June 18, 2025 | News

Pierre Fabre Acquires Global Rights to Next-Generation EGFR Inhibitors for Lung Cancer

Pierre Fabre Laboratories are pleased to announce the acquisition from Antares Therapeutics, Inc. ("Antares"), a spin-out of Scorpion Therapeutics, Inc., o...

June 17, 2025 | News

Continuity Biosciences Acquires Focal Medical to Advance Site-Specific Chemotherapy for Pancreatic Cancer

Continuity Biosciences, LLC, a developer of advanced drug delivery technologies, announced the acquisition of Focal Medical, Inc., a North Carol...

June 05, 2025 | News

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal Expanding Rare Disease and Immunology Portfolio

Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a...

June 02, 2025 | News

Waters Corporation Acquires Halo Labs to Advance Analytical Capabilities for Cell and Gene Therapy Development

Waters Corporation announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count i...

May 22, 2025 | News

IDT Biologika Ramps Up Global CDMO Expansion Following SK Bioscience Acquisition

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that IDT Biologika, a...

May 21, 2025 | News

BoomerangFX Launches LeadEngineAI™ Featuring AUVIA™ Across North America, Europe, and Asia-Pacific to Transform Patient Acquisition in Private Healthcare Clinics

BoomerangFX, the leading AI-powered SaaS platform for private-pay healthcare clinics, announced the global launch of LeadEngineAI™, a transform...

May 19, 2025 | News

WuXi Biologics to Divest Leverkusen Plant to Terumo for €150M, Refocuses on Global DP Expansion

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has entered into ...

May 15, 2025 | News

GSK Acquires Efimosfermin from Boston Pharmaceuticals in $2 Billion Deal to Advance Liver Disease Pipeline

Affecting up to 5% of the global population, SLD represents an area of significant unmet medical need with limited treatment options Phase II data show ...

May 15, 2025 | News

QIAGEN Acquires Genoox to Boost AI-Driven Genomic Interpretation for Clinical Labs Globally

Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases Strengthens QIAGEN Digital Insights...

May 13, 2025 | News

Waters Integrates MALS into Empower™ Software to Accelerate Biologics QC and Slash Validation Time

Saves up to six months on compliant software validation in biopharmaceutical quality control. Reduces analysis time for biotherapeutic peptides and prot...

May 07, 2025 | News

PCI Pharma Services Acquires Ajinomoto Althea’s Altair to Build Global Powerhouse in Aseptic Filling and Advanced Drug Delivery

PCI Pharma Services ("PCI") is pleased to announce the launch of Ajinomoto Althea, the world's leading contract research and manufacturing organi...

May 05, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

Suvoda and Greenphire Merge to Create Unified Platform for Streamlining Clinical Trials

Suvoda, a global clinical trial technology company specializing in randomization and trial supply management, consent, and patient outcomes data collection...

April 25, 2025 | News

Stay Connected